相关实验视频
Updated: Feb 7, 2026

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
Published on: August 29, 2016
目前使用临床前模型来评估基于人类腺病毒的癌症治疗方法
David K Cole1, Rahul C Khanolkar1, James A Davies1
1Accession Therapeutics Ltd, ARC Oxford North, Oxford, UK.
人类腺病毒 (HAdV) 正在作为癌症疗法出现. 由于复杂的修饰和宿主相互作用,开发瘤性HAdV (oHAdV) 的动物模型具有挑战性.
科学领域:
- 瘤治疗性病毒疗法
- 癌症基因治疗的基因疗法
- 病毒载体的发展向量.
背景情况:
- 人类腺病毒 (HAdV) 在癌症治疗方面显示出新的希望,最近获得批准和晚期临床试验.
- 治疗性瘤治疗HAdVs (oHAdVs) 是为了癌细胞选择性而设计的,并包括免疫治疗转基因以提高疗效.
- 对oHAdVs的修饰及其复杂的宿主相互作用使临床前模型开发复杂化.
研究的目的:
- 审查用于癌症治疗的基于oHAdV的治疗载体的临床前评估的实验选择.
- 专注于Ad血清型5 (Ad5) 作为最常见的载体血清型.
- 解决oHAdV临床前发展的相关动物模型开发的挑战.
主要方法:
- 审查现有的文献和临床前模型用于瘤性HAdV评估.
- 专注于增强癌症选择性和免疫治疗转基因输送的修改.
- 检查评估毒性,免疫力,疗效和药学动力学方面的挑战.
主要成果:
- 阿德斯蒂拉德林的批准和积极的第3期数据突出显示了oHAdVs的临床潜力.
- 具有转基因的工程oHAdV显示出克服未经修改的病毒局限性的潜力.
- 开发精确的动物模型仍然是oHAdV临床前研究的关键障碍.
结论:
- 治疗oHAdVs的临床前评估需要仔细考虑模型系统.
- 基于Ad5的载体在oHAdV癌症治疗开发中占据着重要地位.
- 对强壮的动物模型进行进一步的研究对于推进oHAdV癌症疗法至关重要.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
相关概念视频
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Self-Evaluation Maintenance Model
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...